New company structure secures position of strength for Accuron MedTech to focus on global MedTech growth opportunities.
Accuron Technologies announced that it will spin out its medtech business. Accuron MedTech Group (Accuron MedTech) is one of Southeast Asia’s largest medical device business, and it will now be established as a leading vertically integrated urology business.
As a result of the spin out, Accuron MedTech will be directly owned by Temasek. The move will allow Accuron MedTech’s management team to better focus on global MedTech growth and investment opportunities. It is anticipated that the process will be completed by March 2019.
Philip Yeo, chairman of Accuron Technologies Limited said, “Accuron MedTech has been managed as an independent division of Accuron Technologies for some time now. The move will allow Accuron Technologies Limited to focus its resources to pursue opportunities in the growing aerospace and industrial businesses.” [APBN]